Skip to main content
Have a personal or library account? Click to login
Botulinum Neurotoxin Treatment of Camptocormia- A Critical Review and Update Cover

Botulinum Neurotoxin Treatment of Camptocormia- A Critical Review and Update

Open Access
|Aug 2026

References

  1. Souques A, Rosanoff-Saloff. La camptocormie; incurvation du tronc, consecutive aux traumatismes du dos et des lombes; considerations morphologiques. Rev Neurol. 1914–15; 28:937–939.
  2. Finsterer J, Strobl W. Causes of camptocormia. Disabil Rehabil. 2011;33(17–18):1702–1703. Epub 2010 Dec 23. PMID: 21182366. DOI: 10.3109/09638288.2010.543750
  3. Kuo SH, Vullaganti M, Jimenez-Shahed J, Kwan JY. Camptocormia as a presentation of generalized inflammatory myopathy. Muscle Nerve. 2009 Dec;40(6):1059–1063. DOI: 10.1002/mus.21403
  4. Srivanitchapoom P, Hallett M. Camptocormia in Parkinson’s disease: definition, epidemiology, pathogenesis and treatment modalities. J Neurol Neurosurg Psychiatry. 2016 Jan;87(1):75–85. Epub 2015 Apr 20. PMID: 25896683; PMCID: PMC5582594. DOI: 10.1212/01.wnl.0000171857.09079.9f
  5. Azher SN, Jankovic J. Camptocormia: pathogenesis, classification, and response to therapy. Neurology. 2005 Aug 9;65(3):355–359.
  6. Laroche M, Cintas P. Bent spine syndrome (camptocormia): a retrospective study of 63 patients. Joint Bone Spine. 2010 Dec;77(6):593–596. PMID: 20620091. DOI: 10.1016/j.jbspin.2010.05.012
  7. Ganos C, Erro R, Abdullah M, Hauck TS, Ciccarone D, Sutherland C, Saiyarsarai P, Marras C, Fox SH, Fasano A, Lang AE, Squires J, Bhatia KP. Frozen in Addiction: A New Wave of Drug-Induced Movement Disorders? Mov Disord. 2025 Dec;40(12):2596–2603. Epub 2025 Oct 17. PMID: 41103206. PMCID: PMC13001704. DOI: 10.1002/mds.70048
  8. Finsterer J, Strobl W. Presentation, etiology, diagnosis, and management of camptocormia. Eur Neurol. 2010;64(1):1–8. Epub 2010 Jun 8. PMID: 20634620. DOI: 10.1159/000314897
  9. Gerton BK, Theeler B, Samii A. Backpack treatment for camptocormia. Mov Disord. 2010 Jan 30;25(2):247–248. PMID: 20077473. DOI: 10.1002/mds.22909
  10. Schroeteler FE, Fietzek UM, Ziegler K, Ceballos-Baumann AO. Upright posture in parkinsonian camptocormia using a high-frame walker with forearm support. Mov Disord. 2011 Jul;26(8):1560–1561. Epub 2011 Apr 25. PMID: 21520281. DOI: 10.1002/mds.23585
  11. Wang F, He L, Zhao H, Guo X. Efficacy of Deep Brain Stimulation for Camptocormia in Parkinson’s Disease: A Systematic Review and Meta-Analysis. J Integr Neurosci. 2023 Jan 5;22(1):11. PMID: 36722246. DOI: 10.31083/j.jin2201011
  12. Jankovic J. Botulinum toxin: State of the art. Mov Disord. 2017 Aug;32(8):1131–1138. Epub 2017 Jun 22. PMID: 28639368. DOI: 10.1002/mds.27072
  13. Karp BI, Alter K. Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm. Semin Neurol. 2016 Feb;36(1):84–91. Epub 2016 Feb 11. PMID: 26866500. DOI: 10.1055/s-0036-1571952
  14. von Coelln R, Raible A, Gasser T, Asmus F. Ultrasound-guided injection of the iliopsoas muscle with botulinum toxin in camptocormia. Mov Disord. 2008 Apr 30;23(6):889–892. PMID: 18307265. DOI: 10.1002/mds.21967
  15. Colosimo C, Salvatori FM. Injection of the iliopsoas muscle with botulinum toxin in camptocormia. Mov Disord. 2009 Jan 30;24(2):316–317. PMID: 18973251. DOI: 10.1002/mds.22249
  16. Fietzek UM, Schroeteler FE, Ceballos-Baumann AO. Goal attainment after treatment of parkinsonian camptocormia with botulinum toxin. Mov Disord. 2009 Oct 15;24(13):2027–2028. PMID: 19645067. DOI: 10.1002/mds.22676
  17. Wijemanne S, Jimenez-Shahed J. Improvement in dystonic camptocormia following botulinum toxin injection to the external oblique muscle. Parkinsonism Relat Disord. 2014 Oct;20(10):1106–1107. Epub 2014 Jun 16. PMID: 24981917. DOI: 10.1016/j.parkreldis.2014.06.002
  18. Matsumoto H, Akahori T, Hatano K, Hashida H. Botulinum toxin treatment of paraspinal muscles for improving abnormal posture in Parkinson’s disease. Basal Ganglia. 2018 May 1;12:1–3. DOI: 10.1016/j.baga.2018.02.002
  19. Todo H, Yamasaki H, Ogawa G, Nishida K, Futamura N, Funakawa I. Injection of Onabotulinum Toxin A into the Bilateral External Oblique Muscle Attenuated Camptocormia: A Prospective Open-Label Study in Six Patients with Parkinson’s Disease. Neurol Ther. 2018 Dec;7(2):365–371. Epub 2018 Aug 9. PMID: 30094699; PMCID: PMC6283798. DOI: 10.1007/s40120-018-0108-x
  20. Jabbari B. Botulinum toxin treatment of Camptocormia. In: Jabbari B, editor. Botulinum Toxin Treatment of Pain disorders. Springer Nature –3rd edition. 2022, pp. 369–370. DOI: 10.1007/978-3-030-99650-5
  21. De Monte D, Squintani GM, Ermanis G, Lavezzi F, Flumignan S, Valiante G, Ercole BH, Belgrado E, Bernardini A, Tereshko Y, Valente M, Rossi S, Lettieri C. Effects of apomorphine, spinal rTMS, and BoNT on camptocormia: an exploratory wearable sensor-based analysis in a patient with MSA. Toxicon. 2026 Mar 20;276:109073. Epub ahead of print. PMID: 41866084. DOI: 10.1016/j.toxicon.2026.109073
  22. Wissel J, Bensmail D, Ferreira JJ, Molteni F, Satkunam L, Moraleda S, Rekand T, McGuire J, Scheschonka A, Flatau-Baqué B, Simon O, Rochford ET, Dressler D, Simpson DM; TOWER study investigators. Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study. Neurology. 2017 Apr 4.88(14):1321–1328. Epub 2017 Mar 10. PMID: 28283596; PMCID: PMC5379931. DOI: 10.1212/WNL.0000000000003789
  23. Amadio E, Mencio M, Carlizza A, Panuccio F, Sellitto G, Ruotolo I, Simeon R, Berardi A, Galeoto G. An Exploratory Study on the Effects of Souchard Postural Gymnastics in Parkinson’s Disease Patients with Camptocormia: A Quasi-Experimental Approach. J Clin Med. 2024 Oct 16.13(20):6166. PMID: 39458116; PMCID: PMC11508808. DOI: 10.3390/jcm13206166
  24. de Sèze MP, Creuzé A, de Sèze M, Mazaux JM. An orthosis and physiotherapy programme for camptocormia: a prospective case study. J Rehabil Med. 2008 Oct;40(9):761–765. PMID: 18843430. DOI: 10.2340/16501977-0252
  25. Kawami Y, Marumoto K, Shiomi Y, Okinishi M, Kozuki T, Oyabu H, Yokoyama K, Nikaido Y, Akisue T. The effect of comprehensive physiotherapy-based rehabilitation on stooped posture in Parkinson’s disease. J Phys Ther Sci. 2018 Dec;30(12):1440–1445. Epub 2018 Nov 21. PMID: 30568331; PMCID: PMC6279693. DOI: 10.1589/jpts.30.1440
  26. Gandolfi M, Tinazzi M, Magrinelli F, Busselli G, Dimitrova E, Polo N, Manganotti P, Fasano A, Smania N, Geroin C. Four-week trunk-specific exercise program decreases forward trunk flexion in Parkinson’s disease: A single-blinded, randomized controlled trial. Parkinsonism Relat Disord. 2019 Jul;64:268–274. Epub 2019 May 3. PMID: 31097299. DOI: 10.1016/j.parkreldis.2019.05.006
DOI: https://doi.org/10.5334/tohm.1230 | Journal eISSN: 2160-8288
Language: English
Page range: 46 - 46
Submitted on: Apr 29, 2026
Accepted on: Jul 18, 2026
Published on: Aug 5, 2026
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services

© 2026 Ava G. Tohidian, Ali Ghaseminejad-Bandpey, Bahman Jabbari, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.